Impact of Imprinted Immunity Induced by mRNA Vaccination in an Experimental Animal Model.

Authors:
Fujita S; Uriu K; Pan L; Nao N; Tabata K and 10 more

Journal:
J Infect Dis

Publication Year: 2023

DOI:
10.1093/infdis/jiad230

PMCID:
PMC10582899

PMID:
37369369

Journal Information

Full Title: J Infect Dis

Abbreviation: J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential conflicts of interest. SF has an honorarium for a lecture from ROYAL CANIN JAPON, Inc. NN has consulting fees from Fasmac Co., Ltd. HS has royalties from Shionogi & Co., Ltd., honoraria for lectures from Tenshi College, and is a coinventor of a patent (JP 7236065 B1, “Pharmaceutical composition containing triazine derivative”). JI has consulting fees and honoraria for lectures from Takeda Pharmaceutical Co. Ltd. KS has consulting fees from Moderna Japan Co., Ltd. and Takeda Pharmaceutical Co. Ltd. and honoraria for lectures from Gilead Sciences, Inc., Moderna Japan Co., Ltd., and Shionogi & Co., Ltd. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."

Evidence found in paper:

"Financial support. This study was supported in part by AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers “UTOPIA” (Grant JP223fa627001; to KS), AMED SCARDA Program on research and development of new-generation vaccine including new modality application (Grant JP223fa727002; to KS); AMED SCARDA World-leading Institutes for Vaccine Research and Development Hokkaido Synergy Campus (Grant JP223fa627005; to HS, TF, and KM); AMED Research Program on Emerging and Re-emerging Infectious Diseases (Grants JP22fk0108146 [to KS], JP21fk0108493 and JP22fk0108617 [to TF], JP21fk0108494 [to G2P-Japan Consortium, TF, and KS], JP21fk0108425 [to KS], and JP21fk0108432 [to TF and KS]); AMED Research Program on HIV/AIDS (Grant JP22fk0410039; to KS); AMED CREST (Grant JP22gm1610008; to TF); JST PRESTO (Grant JPMJPR22R1; to JI); AMED Japan Program for Infectious Diseases Research and Infrastructure (Grant JP22wm0125008; to HS); JST CREST (Grant JPMJCR20H4; to KS); JSPS KAKENHI Grant-in-Aid for Scientific Research B (Grant 21H02736; to TF); JSPS KAKENHI Grant-in-Aid for Early-Career Scientists (Grant 20K15767; to JI); JSPS Core-to-Core Program (A. Advanced Research Networks) (Grant JPJSCCA20190008; to KS); JSPS Research Fellow DC2 (Grant 22J11578; to KU); JST SPRING (Grant JPMJSP2108; to SF); World-leading Innovative and Smart Education (WISE) Program 1801 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to NN). Financial support."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025